Published in J Pharm Pharmacol on July 01, 2004
Pharmacological and immunological targeting of tumor mesenchymalization. Pharmacol Ther (2016) 0.75
Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol (2010) 1.51
Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer. Lung Cancer (2010) 1.17
Antitumor activity of noscapine in human non-small cell lung cancer xenograft model. Cancer Chemother Pharmacol (2008) 1.16
Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer. Clin Cancer Res (2009) 1.12
Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the Malvern Spraytec. J Pharm Sci (2004) 1.11
Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size, and dynamic surface tension. AAPS PharmSciTech (2005) 1.07
Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer. PLoS One (2011) 1.07
In vitro and in vivo evaluation of topical formulations of spantide II. AAPS PharmSciTech (2005) 1.06
Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers. J Control Release (2010) 1.05
AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies. PLoS One (2013) 1.03
Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model. Pharm Res (2006) 1.01
Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator- activated receptor-gamma. Clin Cancer Res (2004) 0.99
Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer. Mol Cancer Ther (2010) 0.98
Enhanced skin permeation using polyarginine modified nanostructured lipid carriers. J Control Release (2012) 0.96
15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors. Anticancer Drugs (2007) 0.95
Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen. J Control Release (2011) 0.94
Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors. Int J Cancer (2006) 0.92
Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo. J Control Release (2013) 0.91
Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro. J Control Release (2002) 0.90
Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II. Pharm Res (2004) 0.90
Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int J Pharm (2002) 0.90
Dermal microdialysis technique to evaluate the trafficking of surface-modified lipid nanoparticles upon topical application. Pharm Res (2012) 0.87
Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer. PLoS One (2011) 0.86
Evaluation of the Malvern Spraytec with inhalation cell for the measurement of particle size distribution from metered dose inhalers. J Pharm Sci (2004) 0.86
Formulation and in vitro evaluation of transdermal patches of melatonin. Drug Dev Ind Pharm (2004) 0.85
Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models. J Control Release (2013) 0.85
1,1-Bis (3'-indolyl)-1-(p-substitutedphenyl)methane compounds inhibit lung cancer cell and tumor growth in a metastasis model. Eur J Pharm Sci (2013) 0.84
Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation. Mol Pharm (2015) 0.84
Effect of cyclodextrins on the complexation and nasal permeation of melatonin. Drug Deliv (2008) 0.83
Formulation and evaluation of aerosolized celecoxib for the treatment of lung cancer. Pharm Res (2005) 0.82
Evaluation of an aerosolized selective COX-2 inhibitor as a potentiator of doxorubicin in a non-small-cell lung cancer cell line. Pharm Res (2003) 0.81
Coarse-grained kinetic Monte Carlo models: Complex lattices, multicomponent systems, and homogenization at the stochastic level. J Chem Phys (2008) 0.81
Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug. J Aerosol Med (2002) 0.81
Preformulation stability of Spantide II, a promising topical anti-inflammatory agent for the treatment of psoriasis and contact dermatitis. J Pharm Pharmacol (2004) 0.81
Effect of monensin liposomes on the cytotoxicity of anti-My9-bR immunotoxin. J Pharm Pharmacol (2003) 0.80
Subtherapeutic dose of pioglitazone reduces expression of inflammatory adipokines in db/db mice. Pharmacology (2009) 0.80
Structure-property relationship in py-hexahydrocinchonidine diastereomers: ab initio and NMR study. J Phys Chem A (2005) 0.80
Chemoprevention of skin cancer with 1,1-Bis (3'-indolyl)-1-(aromatic) methane analog through induction of the orphan nuclear receptor, NR4A2 (Nurr1). PLoS One (2013) 0.80
Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers. J Biomed Nanotechnol (2015) 0.80
EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer. Pharm Res (2014) 0.80
In vitro and in vivo comparison of dermal irritancy of jet fuel exposure using EpiDerm (EPI-200) cultured human skin and hairless rats. Toxicol Lett (2006) 0.79
Involvement of adipokines in rimonabant-mediated insulin sensitivity in ob/ob mice. J Pharm Pharmacol (2009) 0.79
Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel. Pharm Res (2013) 0.79
Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549. J Pharm Pharmacol (2006) 0.79
Retinol-binding protein 4 : a possible role in cardiovascular complications. Br J Pharmacol (2011) 0.79
Nose-to-brain transport of melatonin from polymer gel suspensions: a microdialysis study in rats. J Drug Target (2011) 0.78
Estimation of proinflammatory biomarkers of skin irritation by dermal microdialysis following exposure with irritant chemicals. Toxicology (2007) 0.78
Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques. Nanomedicine (Lond) (2014) 0.78
Brownian diffusion and surface kinetics of liposome and viral particle uptake by human lung cancer cells in-vitro. Ann Biomed Eng (2006) 0.78
Dermal microdialysis of inflammatory markers induced by aliphatic hydrocarbons in rats. Toxicol Lett (2008) 0.78
Switching of PET fluorescence signals induced by ligand exchange reactions of N-(9-anthrylmethyl)amine on Cu(II) complexes and its application to postcolumn detection of glyphosate. Anal Sci (2005) 0.77
Effect of jet fuels on the skin morphology and irritation in hairless rats. Toxicology (2002) 0.77
Chemopreventive effect of a novel, selective TACE inhibitor on DMBA- and TPA-induced skin carcinogenesis. Immunopharmacol Immunotoxicol (2014) 0.77
Pharmacokinetic evaluation and in vitro-in vivo correlation (IVIVC) of novel methylene-substituted 3,3' diindolylmethane (DIM). Eur J Pharm Sci (2012) 0.77
Opening up the optical imaging window using nano-luciferin. Pharm Res (2014) 0.77
Epithelial transport of noscapine across cell monolayer and influence of absorption enhancers on in vitro permeation and bioavailability: implications for intestinal absorption. J Drug Target (2014) 0.77
Chapter 9 - Nanoliposomal dry powder formulations. Methods Enzymol (2009) 0.76
Effects of leptin and neuropeptide-Y on transcript levels of thyrotropin beta and common alpha subunits of rat pituitary cells in vitro. Life Sci (2004) 0.76
Stability and degradation profiles of Spantide II in aqueous solutions. Eur J Pharm Sci (2005) 0.76
Evaluation of Spray BIO-Max DIM-P in Dogs for Oral Bioavailability and in Nu/nu Mice Bearing Orthotopic/Metastatic Lung Tumor Models for Anticancer Activity. Pharm Res (2015) 0.76
Enhanced Percutaneous Delivery of 1,1-bis(3'-indolyl)-1-(p-chlorophenyl) Methane for Skin Cancer Chemoprevention. J Biomed Nanotechnol (2015) 0.76
Selective inhibition of tumor necrosis factor-α converting enzyme attenuates liver toxicity in a murine model of concanavalin A induced auto-immune hepatitis. Int Immunopharmacol (2013) 0.75
Preparation of silica sphere with porous structure in supercritical carbon dioxide. J Colloid Interface Sci (2010) 0.75
Building a kinetic Monte Carlo model with a chosen accuracy. J Chem Phys (2013) 0.75
Evaluation of metered dose inhaler (MDI) formulations of ciclosporin. J Pharm Pharmacol (2007) 0.75
An off-lattice, self-learning kinetic Monte Carlo method using local environments. J Chem Phys (2011) 0.75
Accuracy of a Markov state model generated by searching for basin escape pathways. J Chem Phys (2013) 0.75
Steep atomic dispersion induced by velocity-selective optical pumping. Opt Express (2008) 0.75
Molecular cloning and sequence analysis of the cDNA encoding thyroid-stimulating hormone beta-subunit of common duck and mule duck pituitaries: in vitro regulation of steady-state TSHbeta mRNA level. Comp Biochem Physiol B Biochem Mol Biol (2006) 0.75
Blockade of tumor necrosis factor-α converting enzyme (TACE) enhances IL-1β and IFN-γ via caspase-1 activation: a probable cause for loss of efficacy of TACE inhibitors in humans? Eur J Pharmacol (2012) 0.75
Effect of combination of hydrophilic and lipophilic permeation enhancers on the skin permeation of kahalalide F. J Pharm Pharmacol (2014) 0.75